a b s t r a c t INTRODUCTION: Choroidal metastasis from colorectal cancer is rare, and there have been no reported cases of such metastasis from early colorectal cancer. We report a case of choroidal metastasis from early rectal cancer.
Introduction
Primary tumors with choroidal metastases include, those originating from the lungs, breast and gastrointestinal tract, and were very rare in patients with carcinoma of the colon or rectum. Here, we report a case of choroidal metastasis from early rectal cancer.
Case presentation
A 60 year-old-man with a positive fecal occult blood test was diagnosed with early rectal cancer and underwent endoscopic mucosal resection at another hospital. Pathological findings showed well-differentiated adenocarcinoma with submucosal invasion(SM; 3500 m), lymphatic infiltration (ly1), and no venous invasion (v0). A horizontal and vertical cut margin was negative ( Fig. 1 ). According to the Japanese Society for Cancer of the Colon and Rectum (JSCCR) 2010 guidelines for the treatment of colorectal cancer, 1 the patient underwent laparoscopic low anterior resection with D2 lymphadenectomy. Final pathological findings revealed no residual tumor cell in the rectum and one metastasis in regional lymph nodes (1/15 The patient received postoperative adjuvant chemotherapy with uracil-tegafur (UFT) plus leucovorin for six months. Two years after radical rectal surgery, a metastasis in left lung was detected by computed tomography (CT). No metastases were detected in other organs. The patient underwent thoracoscopic partial pulmonary resection. Pathological findings revealed metastatic tubular adenocarcinoma in the lung and the surgical cut margin was negative.
Six months after pulmonary resection, the patient experienced left sided myodesopsia, examination for which showed a white and yellow choroidal mass. CT scan of the brain demonstrated a metastatic lesion in the left eye ( Fig. 2a and b) . A repeat CT scan of chest demonstrated the presence of multiple metastases in both lungs ( Fig. 3a and b ). No other metastatic lesions or recurrences were detected. The patient elected to undergo radiotherapy for his choroidal metastasis. After radiotherapy (45 Gy/25 fr) to the left eye, bevacizumab + CapeOX (capecitabine + oxaliplatin) was initiated for 18 months and bevacizumab + FOLFIRI was continued for 9 months until the time. The patient has survived for 2 years and 3 months without signs of recurrence in the left eye and is receiving ongoing systemic chemotherapy for multiple lung metastases.
Discussion
Regarding ocular malignancy, metastatic tumors are becoming more common than primary tumors, and are mainly found in the choroid. Primary tumors with choroidal metastases include, those originating from the lungs, breast and gastrointestinal tract at frequencies of 47%, 21%, 4%, respectively. 2 Amemiya et al. reported that orbital metastases more frequently arise from the liver and stomach in Japan compared to the United States and Europe, and were very rare in patients with carcinoma of the uterus, ovaries, bladder, pancreas, colon or rectum. 3 We searched the PubMed database through 2014 and the Japanese Ichushi database of the Japan Medical Abstracts Society (http://www.jamas.or.jp/) from 1983 through 2014, using the following search terms: "choroidal metastasis," "colorectal," and "cancer." The results identified 14 patients in addition to the current patient who underwent primary colorectal tumor resection (Table 1) . [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] The mean age of the patients was 54.2 years (range 30-79 years). Of the 14 patients, 10 were males. Five patients had colon cancer and 9 patients had rectal cancer. Regarding T stage, only our case was T1; all others were T3 or T4a. The current case is the first report of choroidal metastasis from early colorectal cancer.
Four patients had a diagnosis of synchronous choroidal metastases, and 10 patients had metachronous metastases, which were diagnosed at a mean of 23.8 months after primary tumor resection. The major symptom was vision loss in 7 patients, blurring of vision in 3 patients, photopsia in one patient, cloudy vision in one patient, eye pain in one patient and myodesopsia in one patient.
Choroidal metastasis from colorectal cancer has an unfavorable prognosis. When choroidal metastasis was diagnosed, it was accompanied with metastases to another organ in all patients from our search. Of the 14 patients, 11 patients died because of progression of the other organ metastases after diagnosis of the choroidal metastasis. The mean survival time was 5.6 months (range, 1-12) in all cases, excluding ours from the analysis.
Regarding treatment of choroidal metastases, systemic chemotherapy, [14] [15] [16] radiotherapy, 4 chemoradiotherapy 9-11 and intravitreal bevacizumab therapy 13, 15 were all reported. There were two reports of enucleation before the current standard Table 1 Clinical course in patients with choroidal metastasis as reported in the literature.
Author
Year chemotherapy, namely FOLFOX and FOLFIRI was established. 5, 7 In 3 patients who received systemic chemotherapy, two patients had good response of the choroidal metastasis, 14, 16 but ultimately succumbed because of the other organ metastases. Using radiotherapy, Cole et al. reported that choroidal metastasis had enlarged one month after treatment. 4 In the 3 patients who received chemoradiotherapy, Nakamura et al. reported a patient who survived for 1 year without recurrence of choroidal metastasis and other organ metastases after systemic chemotherapy and radiotherapy for the right eye. 9 In two patients who received intravitreal bevacizumab therapy, Kuo et al. reported upon one had successful short-term regression of choroidal metastasis. 13 Lin et al. reported that intravitreal bevacizumab successfully treated choroidal metastasis in one eye but failed to do so in the other eye. 15 The current literatures have few recommendations regarding the appropriate treatment of choroidal metastasis from colorectal cancer, but an aggressive multi-disciplinary approach that includes chemotherapy, radiotherapy, chemoradiotherapy, and intravitreal bevacizumab therapy may be effective in local regression. With the current case, radiotherapy was chosen. The lung metastases already presented at the time of the choroidal metastasis, making it is important to also enforce systemic chemotherapy in addition to radiotherapy.
Conclusion
This is the first report of choroidal metastasis from early rectal cancer. In our case, radiotherapy was effective for choroidal metastasis. More experience and a long-term follow up are needed to establish the optimal treatment strategy for choroidal metastasis from colorectal cancer.
